scPharmaceuticals Inc. Prices 6.4M Share IPO at $14/Sh

scPharmaceuticals Inc. (NASDAQ: SCPH) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs, today announced the pricing of its initial public offering of 6,400,000 shares of common stock at a public offering price of $14.00 per share, before underwriting discounts and commissions, for gross proceeds of $89.6 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to 960,000 additional shares of common stock at the initial public offering price, less the underwriting discount. The Company’s common stock is expected to begin trading on The Nasdaq Global Select Market under the ticker symbol "SCPH" on November 17, 2017. The offering is expected to close on November 21, 2017 subject to customary closing conditions.

Jefferies, Leerink Partners and BMO Capital Markets are acting as joint book-running managers for the offering.

You May Also Be Interested In

• Lyntris opens at $15.50, below IPO price of $17.50
• Bentley Systems promotes Andy Rahden to chief revenue officer
• Vogenx raises $81.3M in Nasdaq IPO managed by JonesTrading